These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 4612281)

  • 21. Naftidrofuryl in the treatment of recent stroke. Results of a controlled clinical trial.
    Steiner TJ
    Vasa Suppl; 1988; 24():44-7. PubMed ID: 3062824
    [No Abstract]   [Full Text] [Related]  

  • 22. [Statistical studies on the results of stroke therapy].
    Eichhorn O; Auell KH; Dörfler L
    Med Klin; 1965 Dec; 60(52):2100-4. PubMed ID: 5333324
    [No Abstract]   [Full Text] [Related]  

  • 23. [Coronary diseases, hyperuricemia and benziodarone. Personal considerations].
    Veglia L
    Minerva Med; 1974 Oct; 65(72):3795-8. PubMed ID: 4608791
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinico-statistical controlled evaluation of the anti-anginous and myocardiotropic activity of a new substance: 2-benzofuryl-p-chlorophenyl carbinol (Chloridarol)].
    Valiensi M; Del Giallo P
    Minerva Cardioangiol; 1976 Jan; 24(1):25-37. PubMed ID: 768804
    [No Abstract]   [Full Text] [Related]  

  • 25. [Indications for Ustimon and Instenon therapy in cerebrovascular diseases].
    Eichhorn O
    Wien Klin Wochenschr; 1967 Jan; 79(4):67-71. PubMed ID: 5340281
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical studies on the effect of hexobendine (Ustimon) on cerebral circulatory disorders].
    Prosenz P; Tschabitscher H
    Wien Klin Wochenschr; 1965 Dec; 77(48):953-5. PubMed ID: 5331101
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment of cerebrovascular deficiencies. Therapeutic evaluation from 129 cases using the double-blind method against placebo].
    Bargheon J; Durocher AM; Lagrange M
    Sem Hop; 1984 Jan; 60(3):169-74. PubMed ID: 6320441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pharmacokinetic effects of benfurodil hemisuccinate on man after a single dosage (author's transl)].
    Turcant A; Verret JL; Schubert B; Patay M; Allain P
    Therapie; 1979; 34(5):611-8. PubMed ID: 547439
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical considerations on the use of a drug with vasodilating hemokinetic action in cerebral and peripheral vascular diseases].
    Florio F; Ruffolo S; Piro E
    Minerva Cardioangiol; 1976 Feb; 24(2):161-70. PubMed ID: 1256656
    [No Abstract]   [Full Text] [Related]  

  • 30. [Management of cerebrovascular circulation disorders with Tropodil].
    Steinbach M
    Med Klin; 1967 Feb; 62(7):257-9. PubMed ID: 5595330
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical experiences with a vasoactive combination drug].
    Hauck A; Wambsganss E
    Med Welt; 1965 Jun; 24():1338-42. PubMed ID: 5318428
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of cerebral vascular insufficiency syndromes in old age. Controlled research by double blind technic].
    Mars G; Nebuloni G
    G Gerontol; 1970 Mar; 18(3):153-76. PubMed ID: 4919664
    [No Abstract]   [Full Text] [Related]  

  • 33. [The angiographic evaluation of cerebral blood flow; the clinical value of densitometry].
    Huber P
    Schweiz Arch Neurol Neurochir Psychiatr; 1967; 100(1):1-37. PubMed ID: 6055540
    [No Abstract]   [Full Text] [Related]  

  • 34. [The therapeutic effects of flunarizine in peripheral arterial diseases and cerebrovascular diseases].
    De Gregorio G; Restivo S
    Clin Ter; 1982 Dec; 103(5):501-7. PubMed ID: 7160142
    [No Abstract]   [Full Text] [Related]  

  • 35. [Use of encephabol in the combined therapy of chronic cerebral circulatory failure].
    Zinchenko VA
    Vrach Delo; 1984 Aug; (8):36-8. PubMed ID: 6506608
    [No Abstract]   [Full Text] [Related]  

  • 36. [Trial of using Cavinton in cerebrovascular disorders].
    Shtok VN; Eremeeva SV
    Klin Med (Mosk); 1982 Oct; 60(10):39-42. PubMed ID: 6757560
    [No Abstract]   [Full Text] [Related]  

  • 37. [Cerebral circulatory insufficiency. Value of a metabolic active drug].
    Girard PE; Boucher M
    Therapeutique; 1973; 49(5):397-400. PubMed ID: 4781833
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical study of a new vasodilator derived from 5-benzofuran].
    Warembourg H; Lekieffre J; Pommier M
    Lille Med; 1968 Dec; 13(10):Suppl 7:1032+. PubMed ID: 5720285
    [No Abstract]   [Full Text] [Related]  

  • 39. [Utilization of 1035 MD in cerebral ischemia disorders].
    Warot P; Petit H
    Lille Med; 1969 Feb; 14(2):78-82. PubMed ID: 5384128
    [No Abstract]   [Full Text] [Related]  

  • 40. Regional cerebral blood flow and cariovascular effects of hexobendine in stroke patients.
    McHenry LC; West JW; KEnton EJ; Oshiro T; Jaffe ME; Cooper ES; Kawamura J; Goldberg HI
    Neurology; 1972 Mar; 22(3):217-23. PubMed ID: 5062256
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.